Depreciation in USD of Amylyx Pharmaceuticals, Inc. from Q1 2021 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Amylyx Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2021 to Q1 2025.
  • Amylyx Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2025 was $156K, a 50.5% decline year-over-year.
  • Amylyx Pharmaceuticals, Inc. annual Depreciation for 2024 was $904K, a 16.9% decline from 2023.
  • Amylyx Pharmaceuticals, Inc. annual Depreciation for 2023 was $1.09M, a 123% increase from 2022.
  • Amylyx Pharmaceuticals, Inc. annual Depreciation for 2022 was $487K, a 837% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

Amylyx Pharmaceuticals, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $156K -$159K -50.5% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q1 2024 $315K +$111K +54.4% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q1 2023 $204K +$169K +483% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $35K +$25K +250% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $10K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12

Amylyx Pharmaceuticals, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $904K -$184K -16.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-04
2023 $1.09M +$601K +123% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-04
2022 $487K +$435K +837% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $52K Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.